Syngene International Share Price Target 2024 – 2035

NSE: SYNGENE, BSE BOM: 539268, Share Price Target, Stock Price Targets, Future Prediction, Prognosis, Forecast 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2031, 2032, 2035

In this post, you can check the prediction of Syngene International share price target from the present time to the next 10 to 15 years, which will give you some idea about the level to which Syngene International share price has the potential to reach in the coming years. A custom algorithm has been used for these price targets or predictions based on deep learning and keeps changing based on price fluctuations, volume shifts, and market cycles.

Share Price Targets Last Updated on Nov 27, 2024 at 9:06:33 AM

Syngene International Share Price Target in the Next 1, 3, 5, 7, and 10 Years

Below you can see Syngene International long-term share price targets for the next 1, 3, 5, 7, and 10 years

• If we talk about the future stock price target of Syngene International then it can rise to the minimum price of ₹1,244.52 and the maximum price of ₹1,322.36 in the coming 3 years.
• If we estimate the price target for the next 5 years, its value may rise to a minimum price of ₹1,455.33 and a maximum price of ₹1,556.59.
• If we forecast the next 7 years its value can increase to a minimum price of ₹1,680.38 and a maximum price of ₹1,806.64.
• In the next 10 years, it can increase to a minimum price of ₹2,018.26 and a maximum price of ₹2,182.07.

Also Read: CIpla Share Price Target

Syngene International Share Price Target 2024, 2025, 2026, 2027, 2028, 2030, 2032, 2035

Also Read: Abbott India Price Target

Syngene International Share Price Target 2024

The current trend of the stock market is likely to remain the same with more or less volatility and the share price of Syngene International may reach the minimum price of x and the maximum price of x.

• The initial share price target for Syngene International in 2024 is estimated at x.
• Under favorable market conditions, the share price of Syngene International may rise to x by the mid-year.
• By the end of the year in 2024, Syngene International share price has the potential to reach x.

Also Read: Sun Pharma Share Price Target

Syngene International Share Price Target 2025

Based on technical analysis, it is estimated that the minimum target price for Syngene International stock could be ₹1,041.40, and the maximum target price is expected to reach ₹1,096.66 by the end of 2025.

• The initial share price target for Syngene International in 2025 is estimated at ₹1,000.01.
• Under favorable market conditions, the share price of Syngene International may rise to ₹1,007.29 by the mid-year.
• By the end of the year in 2025, Syngene International share price has the potential to reach ₹1,096.66.

Also Read: Ajanta Pharma Share Price Target

Syngene International Share Price Target 2026

If we estimate the share price target of Syngene International by the end of 2026, it could reach the minimum price of ₹1,145.99 and the maximum price of ₹1,212.88.

• The initial share price target for Syngene International in 2026 is estimated at ₹1,104.67.
• Under favorable market conditions, the share price of Syngene International may rise to ₹1,114.85 by the mid-year.
• By the end of the year in 2026, Syngene International share price has the potential to reach ₹1,212.88.

Also Read: Marksans Pharma Share Price Target

Syngene International Share Price Target 2027

By the end of 2027, the share price of Syngene International may increase between ₹1,265.21 to ₹1,345.35.

• The initial share price target for Syngene International in 2027 is estimated at ₹1,212.10.
• Under favorable market conditions, the share price of Syngene International may rise to ₹1,242.07 by the mid-year.
• By the end of the year in 2027, Syngene International share price has the potential to reach ₹1,345.35.

Also Read: Granules India Share Price Target

Syngene International Share Price Target 2028

Syngene International share price may rise to a minimum price of ₹1,395.62 and a maximum price of ₹1,490.25 by the end of 2028.

• The initial share price target for Syngene International in 2028 is estimated at ₹1,350.44.
• Under favorable market conditions, the share price of Syngene International may rise to ₹1,381.72 by the mid-year.
• By the end of the year in 2028, Syngene International share price has the potential to reach ₹1,490.25.

Also Read: Alkem Laboratories Share Price Target

Syngene International Share Price Target 2031

By the end of 2031, the share price of Syngene International may increase to a minimum price of ₹1,708.74, and a maximum price of ₹1,838.16.

• The initial price target for Syngene International in 2031 is estimated at ₹1,743.96.
• Under favorable market conditions, the share price of Syngene International may rise to ₹1,775.13 by the mid-year.
• By September the share price of Syngene International may touch the level of ₹1,806.64.
• By the end of the year in 2031, Syngene International share price has the potential to reach ₹1,838.16.

Also Read: Apollo Hospitals Share Price Target

Syngene International Share Price Target 2035

If we look at the long-term growth potential, Syngene International stock has the potential to reach a minimum price of ₹2,159.15 and a maximum price of ₹2,338.61 by the end of 2035.

• The initial price target for Syngene International in 2035 is estimated at ₹2,244.41.
• Under favorable market conditions, the share price of Syngene International may rise to ₹2,275.58 by the mid-year.
• By September the share price of Syngene International may touch the level of ₹2,307.09.
• By the end of the year in 2035, Syngene International share price has the potential to reach ₹2,338.61.

Also Read: KIMS Share Price Target

FAQ: Syngene International Share Price Target

Disclaimer: This article is for informational purposes only and should not be considered investment advice. The price targets or predictions provided are generated by a custom algorithm using deep learning, which may change due to market fluctuations, volume shifts, and market cycles. It is strongly recommended not to base investments solely on the target price mentioned. For complete information read the disclaimer page.